Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Tuesday, May 6, 2008

Choline- and betaine-defined diets for use in clinical research and for the management of trimethylaminuria

Marjorie G. Busby MPH, RD, , Leslie Fischer PhD, MPH, RD, Kerry-Ann Da Costa PhD, Dorothene Thompson, Mei-Heng Mar and Steven H. Zeisel MD, PhD

I highly recommend the purchase of this article for all sufferers who have tested positive for tmau. It is a research supported by grants from the National Institutes of Health to Steven Zeisel, to the University of North Carolina Clinical Nutrition Research Unit and Center for Environmental Health and Susceptibility, and to the University of North Carolina General Clinical Research Center.

A low-choline diet that contains high-quality protein and adequate amounts of breads, fruits, and vegetables can be provided to individuals with trimethylaminuria. Acceptable/palatable meal plans can be developed containing levels of choline as low as 100 mg per day. Meal plans should be developed according to individual preferences using the Dietary Guidelines for inclusion of a variety of foods. Based on the analyses of individual foods previously published, foods were grouped according to three levels of choline for use in developing individualized diets (Table 3). Values for betaine are also provided...

full article:
http://linkinghub.elsevier.com/retrieve/pii/S0002822304015743

0 comments:

Post a Comment